| ALT | alanine aminotransferase |
| ULN | upper limits of normal |
| CYPs | cytochrome P450 family |
| 7-HC | 7-hydroxycoumarin |
| 7-HCG | 7-hydroxycoumarin-glucuronide |
| CE | 3,4-epoxycoumarin |
| o-HPA | o-hydroxyphenylacetaldehyde |
| o-HPAA | o-hydroxyphenylacetic acid |
| GSH | glutathione |
| SGPT | serum glutamic pyruvic transaminase |
| AST | aspartate transaminase |
| gamma-GT/GGT | gamma-glutamyl transpeptidase |
| TDI | Tolerable Daily Intake |
| EFSA | European Food Safety Authority |
| NOAEL | No Observed Adverse Effect Level |
| BfR | German Federal Institute for Risk Assessment |
| ALDH | aldehyde dehydrogenase |
| NAMs | new approach methodologies system |
| NGRA | Next Generation Risk Assessment |